IMMUTEP LIMITED — Director's Dealing 2010

May 6, 2010

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: PRIMA BIOMED LIMITED (ASX: PRR) ABN: 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Martin Rogers Date of Last Notice: 17 September 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Indirect	Indirect
Nature of Indirect Interest(including registered holder) Note: Provide details of the circumstances giving rise to the relevantinterest.		Director related entity
Date of change		7 May 2010
No. of securities held prior to change				Options-12,345,23812,345,238
			Shares	Options
		Direct	-	-
		Indirect	20,497,500	12,345,238
		Total	20,497,500	12,345,238
Class		Fully Paid	Ordinary Shares (PRR)
Number Acquired				Options---
			Shares	Options
		Direct	-	-
		Indirect	324,000	-
		Total	324,000	-

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number Disposed				Options---
			Shares	Options
		Direct	-	-
		Indirect	-	-
		Total	-	-
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation		$46,980
No. of Securities Held After Change				Options-12,345,23812,345,238
			Shares	Options
		Direct	-	-
		Indirect	20,821,500	12,345,238
		Total	20,821,500	12,345,238
Nature of ChangeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back		On-market trade

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder(if issued securities)
Date of Change
No. and Class of Securities toWhich Interest Related Prior toChangeNote: Details are only required for a contract in relationto which the interest has changed
Interest Acquired
Interest Disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation
Interest After Change
The CFO Solution	7.05.2010

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002